Nanoform Finland (STU:4YL) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 27, 2026)


STU:4YL Nanoform Finland PLC STU:4YL
73 GF Score
Price €0.77
GF Value €1.82
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Nanoform Finland Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Nanoform Finland's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

STU:4YL vs VRTX, REGN, ALNY: Margin of Safety % (DCF FCF Based) Comparison

For the Biotechnology subindustry, Nanoform Finland's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nanoform Finland Margin of Safety % (DCF FCF Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanoform Finland's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Nanoform Finland's Margin of Safety % (DCF FCF Based) falls into.


STU:4YL
73GF Score
Nanoform Finland PLC STU:4YL
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nanoform Finland (STU:4YL) Overvalued in 2026?

Based on GuruFocus' analysis, Nanoform Finland stock appears to be undervalued. The current stock price of €0.77 is trading 57.5% below its estimated GF Value™ of €1.82. GuruFocus considers Nanoform Finland to be Possible Value Trap.

Key valuation signals for STU:4YL:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: €1.82 vs. price of €0.77 (57.5% below fair value)
  • GF Score™: 73/100 with 4 warning signs

No single metric tells the full story. See the STU:4YL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nanoform Finland Business Description

Address Cultivator II, Viikinkaari 4, Helsinki, FIN, 00790
Nanoform Finland PLC is a nanoparticle medicine-enabling company. The company works together with pharma and biotech partners to reduce attrition in clinical trials and enhance their molecules' formulation performance through its nano-forming services. Its patented and scalable Controlled Expansion of Supercritical Solutions (CESS) technology produces nano-formed API particles as small as 10nm. This enables poorly soluble molecules in the pharmaceutical pipeline to progress into clinical development by increasing their rate of dissolution and improving their bioavailability. Its technology provides novel opportunities in many value-enhancing drug delivery applications. Geographically, the company generates maximum revenue from Europe, followed by the United States and other regions.
73GF Score

Get the complete analysis for STU:4YL

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.77
Price
€1.82
GF Value